Related Experiment Video
Updated: Jul 15, 2026
17:59
Derivation of Thymic Lymphoma T-cell Lines from Atm-/- and p53-/- Mice
Published on: April 3, 2011
Characterization of a human plasmacytoma line
S S Weinreich1, A E von dem Borne, R A van Lier
1Central Laboratory of The Netherlands Red Cross Blood Transfusion Service, Amsterdam.
British Journal of Haematology
|October 1, 1991
Summary
A new multiple myeloma cell line, TH, exhibits unique characteristics and responses to IL-6. This discovery offers potential for developing new therapies and understanding myeloma cell growth factors.
Area of Science:
- Hematology
- Cell Biology
- Immunology
Background:
- Multiple myeloma is a cancer of plasma cells.
- Characterizing novel cell lines is crucial for understanding disease mechanisms and developing therapies.
Purpose of the Study:
- To establish and characterize a new human multiple myeloma cell line (TH).
- To investigate the role of Interleukin-6 (IL-6) in the growth and differentiation of this cell line.
Main Methods:
- Establishment of the TH cell line from a multiple myeloma patient.
- Ultrastructural analysis, karyotyping, and immunophenotyping.
- Assessment of IL-6 effects on proliferation and secretion.
Main Results:
- The TH cell line displays significant heterogeneity and chromosomal abnormalities.
- TH cells express specific antigens (PCA-1, CD9, CD28, CD38) and kappa light chains.
- IL-6 enhances TH cell proliferation, kappa light chain secretion, and CD28/CD38 expression.
Conclusions:
- The TH cell line provides a valuable model for studying multiple myeloma.
- Its unique B-cell marker profile may aid in developing monoclonal antibodies for plasma cell targeting.
- IL-6 acts as a paracrine growth and differentiation factor for myeloma cells.
